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SRGAP2 (Slit–Robo GTPase-activating protein 2) is a cytoplasmic protein
found to be involved in neuronal branching, restriction of neuronal migration
and restriction of the length and density of dendritic postsynaptic spines.
The extended F-BAR (F-BARx) domain of SRGAP2 generates membrane
protrusions when expressed in COS-7 cells, while most F-BARs induce the
opposite effect: membrane invaginations. As a ﬁrst step to understand this
discrepancy, the F-BARx domain of SRGAP2 was isolated and crystallized after
co-expression with the carboxy domains of the protein. Diffraction data were
collected from two signiﬁcantly non-isomorphous crystals in the same
monoclinic C2 space group. A correct molecular-replacment solution was
obtained by applying a molecular symmetry-constrained systematic search
approach that took advantage of the conserved biological symmetry of the
F-BAR domains. It is shown that similar approaches can solve other F-BAR
structures that were previously determined by experimental phasing. Diffraction
data were reprocessed with a high-resolution cutoff of 2.2 A˚, chosen using less
strict statistical criteria. This has improved the outcome of multi-crystal
averaging and other density-modiﬁcation procedures.
1. Introduction
SRGAP2 regulates dendritic spine maturation, neuronal
migration and neuronal branching (Charrier et al., 2012;
Guerrier et al., 2009) by coordinating the dynamics of the
plasma membrane with the actin-based cytoskeleton (Fritz et
al., 2015; Pertz et al., 2008; Wong et al., 2001). To achieve this
task, SRGAP2 and the other members of the SRGAP family
(humans have four members: SRGAP1–4) utilize a unique
domain composition, with an amino-terminal extended
F-BAR (F-BARx) domain followed by RhoGAP and SH3
domains, mediating membrane association, cytoskeleton
remodelling and protein–protein interactions, respectively.
Binding studies of SRGAP proteins to their ligands (e.g. the
Robo1 receptor) and a low-resolution small-angle X-ray
scattering (SAXS) structure of full-length SRGAP4 suggest
that the RhoGAP and SH3 domains directly interact with the
F-BARx domain, and thus the three domains function in a
cooperative manner (Guez-Haddad et al., 2015).
The three-dimensional shape of F-BAR (FES-CIP4
homology) domains, as well as of the other members of the
BAR superfamily [i.e. BAR (Bin/amphiphysin/RVS), I-BAR
(inverse BAR) and N-BAR (N-terminal BAR) domains], is
directly linked to their function (Frost et al., 2009; Peter et al.,
2004; Kessels & Qualmann, 2015). BAR domains that have
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concave membrane-binding ‘N-surfaces’ associate with
membrane invaginations, while I-BARs that have convex
N-surfaces associate with protrusions. All BAR domains
form elongated antiparallel dimers, in which each protomer
contains three primary helices (helices 1–3; Fig. 1a). At the
centre of the dimer, where the two protomers overlap, a six-
helix bundle is formed, leaving two protruding coiled-coil
arms at the periphery of the dimer. F-BAR family members
that have had their crystal structures determined [i.e. FBP17,
syndapin, FCHo2, Rgd1p, Imp2 and FES; PDB entries 2efk
and 2eﬂ (Shimada et al., 2007), 3hah (Wang et al., 2009), 2v0o
(Henne et al., 2007), 4wpe (Moravcevic et al., 2015), 5c1f
(McDonald et al., 2016) and 4dyl (Structural Genomics
Consortium, unpublished work)] show concave N-surfaces,
consistent with their membrane invagination-inducing activity.
However, the F-BARx of SRGAP2 is different. It is the largest
F-BAR (500 residues), mostly owing to a 150-residue ‘Fx’
carboxy-extension coiled coil. Also, when SRGAP2 is
expressed in COS-7 cells it inﬂicts a robust membrane-
protrusions phenotype, the opposite effect to the other
F-BARs (Yamazaki et al., 2013; Guerrier et al., 2009). The
larger size and inverse membrane-remodelling activity of the
SRGAP2 F-BARx probably reﬂect signiﬁcant structural
deviation from the canonical F-BAR structure. These differ-
ences were considered carefully when selecting search models
for molecular-replacement (MR) phasing.
A signiﬁcant proportion (around 40%) of the coiled-coil
protein structures determined to date have been phased by
experimental methods, as estimated using a PDB keyword
search (Rose et al., 2015). For these proteins, MR often fails
owing to poor sequence conservation and relative movements
of helices in the coiled-coil regions. Moreover, the long
-helical fragments, which are parallel within the single
molecule and between neighbouring crystallographically and
noncrystallographically related molecules, create multiple
identical self- and cross-Patterson vectors, which are highly
confusing in standard MR methods (Dauter, 2015). In fact, all
of the six primary F-BAR structures mentioned above were
determined by experimental phasing, including Imp2, which is
relatively similar to Rgd1p, and for which MR was reported to
have failed (McDonald et al., 2016).
Recently, signiﬁcant improvements in methods of structure
prediction, coupled with the increased power of density-
modiﬁcation techniques, have greatly increased the success of
phasing of coiled-coil proteins by MR methods; for example,
by using a remote or theoretical model, as performed by
Rosetta (Shortle et al., 1998) or QUARK (Xu et al., 2012). This
is carried out by creating an assembly of most probable coiled
models with ideal helices and putting each of these models
through an MR/density-modiﬁcation pipeline such asAMPLE
(Bibby et al., 2012) or CCSolve (Ra¨misch et al., 2015). Usually,
the success of these methods depends on the resolution of the
data. For some high-resolution cases the structure could be
resolved by density modiﬁcation, e.g. the SHELXE phase-
extension procedure (Thorn & Sheldrick, 2013), when only a
part of the structure is correctly positioned (Thomas et al.,
2015). Lower resolution cases, and in particular larger
proteins, are usually more challenging since they require
better initial positioning of the model helices and more user
involvement.
For some cases where the rotation-function (RF) step of
MR cannot ﬁnd a correct orientation, the structures of several
nucleic acid (Rabinovich & Shakked, 1984) and protein
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Figure 1
Conservation and variability in F-BAR structures. (a) Transverse (top),
side (middle) and bottom views of the canonical F-BAR structure,
illustrating the F-BAR domain of FBP17 (PDB entry 2eﬂ) as an example.
F-BAR domains are composed of three -helices and are arranged as
homotypic antiparallel dimers. The overlapping centre of the dimer is
designated the six-helix core, and the remaining portions of helices 2 and
3 that extend from the six-helix core are the F-BAR arms. Generally,
F-BARs bind membranes through their ‘N-surface’ that includes the
N-terminal helix 1. This way, an F-BAR domain with a concave N-surface
will associate with cellular membrane invaginations. The sequence
conservation between different F-BAR domains is low, with the
exception of a speciﬁc sequence signature at the helix 1 homotypic
interface, with a conserved tyrosine side chain stacked at the centre of the
symmetry dyad (seen in the transverse and bottom views, and in Fig. 4e).
(b) The superposition of several F-BAR structures demonstrates the
structural conservation in the six-helix core region, which is in contrast to
the variability of the positions of the F-BAR arms. (c) Based on the
structural F-BAR conservation in the core region, search model B does
not include the F-BAR arms. (d) Search models C and C0 are based on the
six-helix core dyad.
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molecules (Sheriff et al., 1999) have been solved by an
exhaustive six-dimensional MR search, calculating the trans-
lation function (TF) for each possible model orientation. Such
an evolutionary six-dimensional MR search was implemented
in EPMR (Kissinger et al., 1999), which semi-randomly
explores six-N-dimensional space of rotating and translatingN
molecules simultaneously, thus reducing the search calculation
times.
The NCS-constrained exhaustive search method (Isupov &
Lebedev, 2008) utilizes an approach based on conservation of
the quaternary structure between related proteins. Knowledge
of the molecular symmetry of the target structure and infor-
mation derived from the self-rotation function allows a
limitation of the number of orientations for which the TF
search is conducted and omission of the RF step of the MR
method. Provided the conservation of quaternary structure
was correctly inferred and the NCS was correctly interpreted,
such an approach signiﬁcantly restricts the search space. This
reduces both the calculation times and the probability of
ﬁnding high-scoring false solution. The NCS-constrained
exhaustive search can be conducted with MR programs such
as AMoRe (Navaza, 1994), MOLREP (Vagin & Teplyakov,
2010) and Phaser (McCoy et al., 2007). The NCS-constrained
exhaustive search has successfully been used for the structure
solution of decameric human peroxiredoxin II (Schro¨der et al.,
2000), dodecameric Bacillus anti-TRAP protein (Shevtsov
et al., 2010) and dimeric Pseudomonas 3,6-diketocamphane
monooxygenase (Isupov et al., 2015). A related approach of
NCS-constrained exhaustive model generation was demon-
strated to successfully ab initio phase a structure of the helical
membrane protein MscL by MR (Strop et al., 2007); however,
after test models were generated these were positioned in the
unit cell by conventional MR.
The F-BARx domain (residues 1–484) of SRGAP2 can be
readily expressed in Escherichia coli and puriﬁed, but not with
high enough homogeneity to be suitable for X-ray crystallo-
graphy (Wang et al., 2014). Here, we ﬁrst describe the
expression system that we devised in order to overcome this
obstacle. We next present the puriﬁcation, crystallization
and X-ray diffraction data-collection procedure that we
performed. Finally, we describe the challenges that hampered
the standard MR attempts, and the methodology that we used
to overcome these difﬁculties.
2. Experimental
2.1. Design and cloning of SRGAP constructs
The human SRGAP2 full-length (SRGAP2-FL) cDNA
clone (KIAA0456) was purchased from ImaGenes GmbH.
Human SRGAP4-FL codon-optimized cDNA for bacterial
expression (KIAA0131) was synthesized by GenScript.
SRGAP4-FL and SRGAP2 F-BARx (residues 1–484) inserts
were ligated into a modiﬁed pHis-parallel2 vector (Novagen)
which includes an amino-terminal hexahistidine tag followed
by a TRX fusion protein, a TEV cleavage sequence and a
multiple cloning site. The RhoGAP-SH3-C0 term (SRGAP2
residues 487–1071; Fig. 2b) insert was ligated into a His tag-
deleted pET-28 vector (Novagen). For subcloning, the internal
BamHI digestion site in the SRGAP2 cDNA was mutated.
2.2. Expression and purification
All constructs were expressed in E. coli BL21 Tuner strain
(Novagen) carrying the RIL CodonPlus plasmid, as described
in Barak & Opatowsky (2013). For limited proteolysis, TRX-
SRGAP4-FL was puriﬁed by the following steps: the bacterial
lysate supernatant was loaded onto a pre-equilibrated nickel-
chelate column (HisTrap, GE Healthcare) with buffer A
[50 mM phosphate buffer pH 8, 400 mM NaCl, 5% glycerol,
5 mM -mercaptoethanol (ME)] and then washed and eluted
with a buffer B gradient (50 mM phosphate buffer pH 8,
400 mM NaCl, 5% glycerol, 500 mM imidazole, 5 mM ME).
Protein-containing fractions were pooled, incubated with TEV
protease [1:50(v:v)] and dialyzed overnight at 4C against
buffer A. The protein was then passed through a nickel-
chelate column and further isolated using a size-exclusion
column (HiLoad 26/60 Superdex 200, GE Healthcare) pre-
equilibrated with buffer C (120 mM NaCl, 50 mM phosphate
buffer pH 8, 1 mM DTT). The protein was then concentrated
using a Vivaspin 20 concentrator (Sartorius). For crystal-
lization, F-BARx was co-expressed with RhoGAP-SH3-C0
term. The proteins were puriﬁed on a nickel-chelate column
and incubated with TEV protease as described above.
F-BARx was then further puriﬁed using an increasing salt
gradient on an anion-exchange column (Mono Q GL10/100,
GE Healthcare) pre-equilibrated with buffer D (25 mM Tris
buffer pH 7.4, 1 mM DTT). The F-BARx protein fractions
were analyzed using SDS–PAGE, pooled, concentrated to
18 mg ml1 using a Vivaspin 20 concentrator, divided into
aliquots and ﬂash-frozen in liquid N2.
2.3. Limited proteolysis of SRGAP4
Chymotrypsin (Sigma–Aldrich) was diluted to 10 mg ml1 in
10 mM HEPES pH 7.4, 100 mM NaCl buffer and mixed with
2 mg ml1 SRGAP4. The ﬁnal ratio of protease to protein
substrate was 1:1000, and reactions were performed on ice.
Proteolysis products were excised from SDS–PAGE and
analyzed using LC-ESI-MS/MS.
2.4. Preparation of search models A, B, C and C0
Since all F-BAR domains contain long -helical stretches,
an ideal 30-residue polyalanine helix was generated in Coot
(Emsley et al., 2010) and used as search model A.
The FBP17 F-BAR structure is the closest homologue of the
F-BARx of SRGAP2. It shares only 19% sequence identity
over 64% of the length; however, the central region is
expected to show structural similarity, since other F-BAR
structures that share very little sequence homology have good
structural alignment in this area (Fig. 1). The full atomic model
of FBP17 (PDB entry 2eﬂ) and the F-BARx domain sequence
of SRGAP2 were used to create a sequence-modiﬁed model
with MOLREP (Vagin & Teplyakov, 2010; Lebedev et al.,
2008). The resulting model was truncated to leave only the
research papers
Acta Cryst. (2016). D72, 1241–1253 Sporny et al.  Structure solution of the SRGAP2 F-BARx 1243
electronic reprint
central regions of helices 1–3 (114-amino-acid search model B;
Fig. 1c). Since the asymmetric unit of FBP17 contains a single
protomer in a monoclinic space group, model B was merged
with its crystallographic symmetry mate to create a six-helix
core bundle search model C (Fig. 1d). Model C had a mole-
cular dyad parallel to the crystallographic axis y with the
N-surface pointing in the positive direction of y. Since there is
an equal probability that the N-surface points in the negative
research papers
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Figure 2
Domain organization, expression and crystallization of SRGAP proteins. (a) Limited proteolysis of full-length SRGAP4. Full-length SRGAP4 was
incubated with chymotrypsin for 4 h. Samples were analyzed by SDS–PAGE and identiﬁed by LC-ESI-MS to be the amino and carboxy halves of
SRGAP4, as indicated. (b) The human SRGAP2, SRGAP4 and SRGAP2 deletion mutants used in this study. In the scheme, the F-BARx, RhoGAP and
SH3 domains are indicated and appear as coloured shapes. (c) Expression of F-BARx by co-expression with RhoGAP-SH3-C0 term. E. coli cells
expressing F-BARx co-expressed with RhoGAP-SH3-C0 term were lysed and fractionated into insoluble (P) and soluble (S) fractions. The soluble
fractions were then puriﬁed by metal-chelate nickel chromatography (Ni eluate) and analyzed by SDS–PAGE. Note that co-expression with RhoGAP-
SH3-C0 term (marked with double asterisks) allows good solubilization of the F-BARx (marked with a single asterisk). (d) F-BARx Mono Q ion-
exchange chromatography and SDS–PAGE analysis of the elution proﬁle. The protein elutes in two peaks, indicating heterogeneity in protein size or
conformation. (e) Crystals of F-BARx grown in 0.2M ammonium citrate tribasic pH 7.25, 22% PEG 1500. Single-crystal dimensions were approximately
0.15  0.1  0.01 mm. ( f ) A diffraction image collected on ID29 at ESRF using a PILATUS 6M detector, recorded by long exposure after the data-set
collection was completed.
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direction of y in the crystal, model C was rotated by 180
around the x axis using the CCP4 (Winn et al., 2011) program
LSQKAB (Kabsch, 1976) to create model C0.
2.5. Preliminary MR search
As a ﬁrst attempt, the SRGAP2 F-BARx sequence and data
were submitted to the BALBES–ARP/wARP pipeline (Long
et al., 2008; Langer et al., 2008) on the CCP4 Online web server
(http://www.ccp4.ac.uk/ccp4online). Several search models
based on sequence homology did not yield a convincing MR
solution. Next, BALBES proceeded to use sequence-
nonrelated search models and positioned three chains (one of
PDB entry 2w74 and two of PDB entry 2w00) with a total size
of 494 residues in tight packing (Fig. 3a). These structures
were not related in sequence and structure to the all-helix
target F-BARx, but after ﬁve ARP/wARP rebuild-and-
reﬁnement cycles an electron-density map that showed stacks
of long helices was produced (Fig. 3b). Moreover, twofold
antiparallel symmetry reminiscent of the F-BAR hallmark
signature was clearly present. Helices were placed using Coot
(Emsley et al., 2010) and Buccaneer (Cowtan, 2006), and after
reﬁnement with PHENIX (Adams et al., 2010) electron
density for amino-acid side chains was visible; however, this
could not be matched to the SRGAP2 protein sequence. This
model (solution 1) could not be improved by further reﬁne-
ment or density modiﬁcation.
Next, the SURF option ofMOLREP was used to conduct a
search with the full sequence model (keyword Y) or with the
polyalanine model (keyword A). The rotation function was
calculated at 3 A˚ resolution with an integration radius of 18 A˚
for model A and 25 A˚ for models B and C, and the translation
function (TF) was calculated at 4 A˚ resolution. For the
exhaustive search, only the TF was calculated at 4 A˚ resolu-
tion.
The rotation-function list to 3 A˚ resolution for model A
contained about 70 strong peaks of 6–8 in height. A related
approach has been described previously for ARCIMBOLDO
(Milla´n et al., 2015; Rodrı´guez et al., 2012) and AMPLE
(Thomas et al., 2015). Five helices (solution 2) of a total of 150
amino acids were consequently positioned by a translation
search. In the other case (solution 3), model B was positioned
by MOLREP with a good score. The dimeric model C could
not be conﬁdently positioned in the SRGAP2 unit cell.
2.6. Molecular symmetry-constrained systematic MR search
For the symmetry-constrained search, the MOLREP
rotation-function table was prepared with the polar angles 
and ’ ﬁxed at 90 and 90, respectively, and  varied
between 1 and 180 with 1 increments. The search was
conducted both for the full sequence and the polyalanine
models C and C0. The MOLREP option NP 200 was used to
include all values from the table into a single run. Option
PACK N switches off the packing function and was used to
allow positioning of a dimer onto the crystallographic dyad.
Option NPT 1, which only uses a single peak of the TF, was
necessary to position the model on a crystallographic dyad.
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Figure 3
BALBES MR. (a) ARP/wARP-modiﬁed electron-density map (left) and the ribbon model of the initial BALBES solution (right). The search models
had no sequence or structural homology to SRGAP2, yet the resulting ARP/wARPmap showed stacks of -helices characteristic of F-BAR domains. (b)
Manual placement of helices, followed by several cycles of reﬁnement and rebuilding, resulted in clearly deﬁned helices organized in a way that is
reminiscent of F-BAR structures. However, this structure could not be further reﬁned and did not reveal helix directionality or clear side-chain densities
at any point.
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The program SOLUTION_CHECK (Vagin et al., 1998)
from the MoRDa (Vagin & Lebedev, 2015) molecular-repla-
cement pipeline was used to calculate misset angles and
differences in centre-of-mass positions between MR solutions
and ﬁnal structures. The CCP4 program CPHASEMATCH
was used to calculate the mean phase difference between
models at different stages of reﬁnement and the ﬁnal reﬁned
model. The PHENIX package (Adams et al., 2010) was used to
calculate correlation coefﬁcients between intermediate
models and the ﬁnal weighted REFMAC map.
2.7. Refinement and density modification
All potential solutions for each model were subjected to
rigid-body reﬁnement at 4 A˚ resolution in MOLREP and
REFMAC5 (Murshudov et al., 2011). The resulting models
were isotropically reﬁned in REFMAC5. The reﬁned models
were positioned by MOLREP in the unit cell of crystal 2.
Multi-crystal averaging was conducted using DMMULTI
(Cowtan, 2010). The averaged phases were used as input in
REFMAC5 phased reﬁnement (Pannu et al., 1998). The
SHELXE phase-extension procedure (Thorn & Sheldrick,
2013) and ARP/wARP (Long et al., 2008; Langer et al., 2008)
were also used as density-modiﬁcation techniques. For model
rebuilding in Coot, REFMACmaps calculated using combined




Previously (Guez-Haddad et al., 2015), we successfully used
E. coli for recombinant expression of various human SRGAP2
and SRGAP4 fragments. Of these, the SRGAP2 fragment
spanning residues 1–799, which includes the F-BARx,
RhoGAP and SH3 domains, and full-length SRGAP4 exhib-
ited good expression levels, high solu-
bility and monodisperse peaks in size-
exclusion chromatography. The gel-
ﬁltration elution volume and gradient-
ﬁxation analyses showed that SRGAP
proteins are dimers in solution, consis-
tent with the general principle of F-
BAR-mediated dimerization. Here, we
used limited chymotrypsin digestion of
SRGAP4, followed by LC-ESI-MS
analysis, to probe the structural bound-
aries of the F-BARx domain. This
strategy is useful for structural studies in
identifying sites with enhanced back-
bone ﬂexibility (Gao et al., 2005),
and has successfully been implemented
by us before (Opatowsky et al., 2003;
Guez-Haddad et al., 2015). One of
the most prominent protein fragments
(11 RGLQ . . .YTQR 486) that resisted
a four-hour digestion period spans the
F-BARx domain, which includes the canonical N-terminal F-
BAR domain and an 150-amino-acid extension that is
predicted to harbour two helices, also known as the F-BAR
extension (Fx). Based on the limited proteolysis analysis, we
determined the boundaries and ligated the F-BARx domain of
SRGAP2 (residues 1–484) into a modiﬁed pHis Parallel vector
(Novagen), resulting in a Trx-HisTag-TEV-F-BARx fusion
protein. The expressed protein was found mostly in the inso-
luble fraction, and could not be isolated with high homo-
geneity. Since the larger version of SRGAP2 that also includes
the RhoGAP and SH3 domains shows good solubility, we
hypothesized that the RhoGAP-SH3 module has a chaperone-
like effect on the proper folding and stability of F-BARx. As
co-expression of interacting proteins is an established strategy
to increase solubility for structural studies (Kerrigan et al.,
2011), we co-expressed Trx-HisTag-TEV-F-BARx with the
carboxy half of SRGAP2 (residues 487–1071, ligated into a
kanamycin-resistant His tag-deleted pET-28 vector; Novagen)
in E. coli. Under these conditions, large quantities of soluble
F-BARx were obtained, separated from the carboxy half of
SRGAP2 and puriﬁed to homogeneity using consecutive
metal-chelate, ion-exchange and size-exclusion chromato-
graphy. Importantly, F-BARx retained its solubility better in
phosphate buffer than in Tris or HEPES buffers, presumably
because of strong electropositive patches on the proteins
surface that the phosphate buffer can mask, thereby reducing
aggregation.
3.2. Protein crystallization, data collection and processing
F-BARx was screened for crystallization using a mosquito
Crystal robot (TTP Labtech) against PEGRx HT, PEG/Ion
HT, SaltRx HT, Index HT and Crystal Screen HT (Hampton
Research, Aliso Viejo, California, USA) at 293 and 277 K in
96-well hanging-drop clear polystyrene plates. Drop sizes
were 0.3 ml, with a 1:1 sample:reservoir screen ratio. A
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Table 1
Summary of the data-processing statistics.
Values in parentheses are for the outer resolution shell.
Crystal Crystal 1 Crystal 2
Beamline ID29, ESRF ID29, ESRF
Wavelength (A˚) 0.9763 0.9763
Space group C2 C2
Unit-cell parameters (A˚, ) a = 203.8, b = 29.9, c = 95.0,
 = 90.0,  = 91.9,  = 90.0
a = 216.9, b = 29.6,
c = 94.7,  = 90.0,
 = 92.0,  = 90.0
Solvent content (%) 50.0 52.3
VM (A˚
3 Da1) 2.48 2.60
Processing tool DIALS XDS XDS
Resolution range (A˚) 101.86–2.20 (2.27–2.20) 47.3–2.89 (3.06–2.89) 47.3–2.94 (3.12–2.94)
Multiplicity 2.8 (2.6) 3.7 (3.7) 3.2 (3.0)
Unique reﬂections 28869 13202 12658
Completeness (%) 96.2 (94.0) 98.4 (94.5) 94.9 (78.7)
Rmerge (%)† 15.2 (128.1) 12.1 (73.3) 14.9 (56.2)
hI/(I)i 3.3 (0.7) 7.9 (1.9) 5.3 (1.7)









i IiðhklÞ, where I(hkl) is the intensity of reﬂection hkl,
P
hkl is the sum
over all reﬂections and
P
i is the sum over i measurements of the reﬂection.
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crystallization hit appeared at 293 K in 0.2M ammonium
citrate tribasic pH 7.0, 20%(w/v) polyethylene glycol (PEG)
3350. Crystallization conditions were reﬁned in 24-well
hanging-drop vapour-diffusion plates by varying the pH value
and the molecular mass of the precipitant, after which
diffraction-grade crystals appeared in 0.2M ammonium
citrate tribasic pH 7.25, 22%(w/v) PEG 1500. Several very thin
leaf-shaped crystals were harvested and cryocooled after
being soaked in a cryoprotectant solution consisting of 0.2M
ammonium citrate tribasic pH 7.25, 35%(w/v) PEG 1500.
Diffraction data for two F-BARx crystals were measured on
the tunable beamline ID29 (de Sanctis et al., 2012) at the
European Synchrotron Radiation Facility (ESRF) under
standard cryogenic conditions. Data processing of crystals 1
and 2 was carried out using the XDSAPP software package
(Kabsch, 2010; Krug et al., 2012) to resolutions of 2.89 and
2.94 A˚, respectively. Crystal 1 belonged to space group C2,
with unit-cell parameters a = 203.8, b = 29.9, c = 94.9 A˚,
 = 91.9. Crystal 2 was signiﬁcantly different from crystal 1
(a = 216.9 A˚), with an R factor of 0.41 between the two sets of
structure factors according to the CCP4 program SCALEIT.
This allowed phase improvement by multi-crystal averaging.
Matthews probability calculation (Kantardjieff & Rupp,
2003) suggests the presence of one molecule in the asymmetric
unit and a solvent content of 54%. For the purpose of density
modiﬁcation the diffraction data from crystal 1 were later
reprocessed using both XDS and DIALS (Waterman et al.,
2013) to 2.2 A˚ resolution. The data-collection statistics are
summarized in Table 1.
3.3. Observing ‘ghost helices’
In the course of preliminary MR searches, three potential
solutions were identiﬁed. Several helices were added to the
model when potential MR solution 1 was subjected to the
ARP/wARP procedure. After reﬁnement and multi-crystal
averaging of both potential solutions 2 and 3, the electron
density revealed features which allowed the building of new
helices and extensions of the existing helices. Normally, strong
helical features in the unassigned electron density are very
helpful in building the model, but confusingly, solutions 2 and
3 were distinct from each other and from solution 1, and their
reﬁnement statistics did not improve after adding more
helices.
Such artiﬁcial helical features for coiled-coil proteins are
likely to have been observed previously by other groups in the
ﬁeld, but we could not ﬁnd these described anywhere. Indeed,
we have learned that strong helical features were observed in
other wrongly positioned coiled-coil models (Ronan Keegan,
personal communication).
The term ‘ghost helices’ reﬂects their nature, since their
position depends on that of the starting model. These ‘ghost
helices’ are likely to be related to signiﬁcant non-origin peaks
in the native Patterson function calculated for the SRGAP2
data (Fig. 4c). Such peaks, which are sometimes called
‘phantom’ (Urzhumtsev et al., 2016), are common for crystals
of nucleic acids and coiled-coil proteins. In the SRGAP2 case,
the phantom peaks indicate that the protein contains several
helices with axes approximately normal to the crystallographic
dyad and nearly parallel to each other and to helices from
other asymmetric units.
3.4. Molecular symmetry-constrained search MR
Eventually, we solved the F-BARx structure by applying a
molecular symmetry-constrained systematic search approach,
for which we used the six-helix core bundle of FBP17 as a
search model. The choice of this search model was based on
the observation that in spite of the overall variability within
F-BAR domain structures that have previously been deter-
mined, all have a conserved six-helix core bundle (Figs. 1a and
1b). Since the asymmetric unit of the SRGAP2 F-BARx
crystal contains a single protomer, the molecular dyad of the
biological unit dimer must be located on a crystallographic
twofold axis.
Macromolecular crystals which have one or more oligomer
molecular symmetry axes coinciding with crystallographic
axes are very common. Such a crystal organization restrains
the possible positions of the oligomer in the unit cell, and can
be exploited to simplify MR search/validation or experimental
phasing and phase improvement. For example, the virion
structure of common cold virus (Rossmann et al., 1985) was
situated on a crystallographic threefold axis in the cubic space
group P213. The particle orientation and its centre of mass
were found from the self-rotation function, packing consid-
erations and heavy-atom positions. MIR phases were
extended from 5 to 3 A˚ resolution using 20-fold averaging
and icosahedral molecular symmetry operators. In a second
example, tetrameric tyrosine phenol-lyase (Antson et al.,
1992), which has two monomers per asymmetric unit, was
phased by MIR. Phases were improved by averaging with NCS
operators derived from molecular symmetry 222. In a third
case, a tetramer of a remote homologue could be positioned
on a crystallographic dyad of alcohol dehydrogenase (Guy et
al., 2003) using MAD phases.
The dimer core bundle structure of SRGAP2 (models C and
C0; Fig. 4a) was positioned by a molecular symmetry-
constrained search procedure (Isupov & Lebedev, 2008) that
was adapted for the scenario of an oligomer on a crystallo-
graphic axis. The six-dimensional search in this case was
reduced to two one-dimensional searches. This was achieved
by switching off the packing function in MOLREP and
calculating the TF for all possible rotations of models C and C0
around the crystallographic y axis. The ’ = 80 rotation proved
to be a clear solution (Fig. 4b) for the MOLREP sequence-
modiﬁed model C and for a polyalanine model C, although
with a reduced contrast. The MR search gave the same solu-
tion for data processed with both XDS and DIALS. The mean
phase error calculated for the sequence-modiﬁed and poly-
alanine model solutions (MR solution in relation to the ﬁnal
reﬁned SRGAP2 model) at 40–3.0 A˚ (40–5.5 A˚) resolution
were 87.9 (87.3) and 87.6 (84.6), respectively. The corre-
lations calculated between the sequence-modiﬁed and poly-
alanine MR solutions and the ﬁnal weighted REFMACmap of
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Figure 4
MR solution by the exhaustive molecular-symmetry search approach. (a) Side and top views of the dimeric six-helix core bundle model C located on a
crystallographic twofold axis. Helices from different protomers are shown in different colours. (b) TF searches were performed for both sequence-
modiﬁed models C (top) and C0 (bottom) rotated around the crystallographic twofold axis by the variable angle ’. The correlation coefﬁcient (CC) is
plotted as a function of ’. The highest peak at ’ = 80 for model C corresponds to a correct orientation (marked by an arrow). (c) A diagram showing
native Patterson synthesis calculated using SRGAP2 data at 2.7 A˚ resolution, contoured at 6. The exhaustive-search MR solution is shown as a C trace.
The line connecting the peaks is approximately parallel to the axes of the three helices in the core bundle. (d) Side and top views of the partially reﬁned
SRGAP2 model for which unambiguous amino-acid assignment for the core bundle helices became feasible. (e) The alignment of the SRGAP2 sequence
in the region of the FCH signature motif on the symmetrical helix 1 interface (top). Tyr62 is nearest to the dyad. The 2Fo  Fc electron-density map
calculated using REFMAC combined averaged and partial model phases in the region of the FCH signature motif. The assigned amino-acid side chains
are shown with C atoms from the two crystallographic protomers in different colours (bottom).
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SRGAP2 were 0.21/0.21 at 3.0 A˚ resolution and 0.30/0.33 at
5.5 A˚ resolution, respectively.
3.5. Refinement of the MR solution and density modification
Although the MR solution contrast was higher for the
sequence-modiﬁed model C, the electron-density maps
calculated for the polyalanine model solution revealed more
features after partial reﬁnement and multi-crystal density
averaging, which is consistent with a smaller mean phase error
for this model at low resolution. Therefore, model building
and reﬁnement started from the polyalanine MR solution.
Rigid-body and positional reﬁnement of the starting model
against the 2.89 A˚ resolution XDS-processed data, multi-
crystal averaging and phase combination in REFMAC
suggested the presence of two new helical stretches of about
20 residues in the electron density. This extended model had
a mean phase error of 82.3 at 40.0–3.0 A˚ resolution. After a
further two cycles of model rebuilding/reﬁnement the reﬁne-
ment stalled. The electron-density maps were not showing any
new features and subsequent analysis showed an increase in
mean phase error owing to over-reﬁnement. Inspection of the
model showed that residues in the original three helices did
not keep their main-chain angles in the course of the initial
reﬁnement. With hindsight, PROSMART secondary-structure
restraints (Nicholls et al., 2012) should have been used in the
early stages of REFMAC reﬁnement.
To overcome difﬁculties in reﬁnement, the following two
steps were undertaken. Firstly, the core helices were rebuilt as
ideal in Coot. Secondly, the data for crystal 1 were reprocessed
in bothXDS (Kabsch, 2010) andDIALS to a higher resolution
of 2.2 A˚ and a reference resolution of 2.7 A˚ (Karplus &
Diederichs, 2012; Evans & Murshudov, 2013).
The over-reﬁned model could not be rescued by reﬁnement
and density modiﬁcation with higher resolution data.
However, when SHELXE and multi-crystal averaging were
applied to the rebuilt helix model, a signiﬁcant improvement
in the quality of the electron-density maps was observed for
higher resolution data. TheDIALS data had a CC1/2 of around
0.3 in the highest resolution shell (Table 1) and were chosen
for further reﬁnement, since data processed in XDS had a
signiﬁcantly lower CC1/2 in the last shell. The rebuilt model
containing three core and two additional helices had a mean
phase error of 75.4 (correlation of 0.53 to the ﬁnal REFMAC
weighted map) at 3 A˚ resolution after REFMAC reﬁnement
against reprocessed data.
Model rebuilding was performed conservatively, using maps
from SHELXE and REFMAC, with the PDB output of the
ARP/WARP procedure used for side-chain assignment.
Additional helical features and protein side chains were added
only when they were clearly visible in the electron density
calculated for combined averaged/partial model phases
(Pannu et al., 1998). Three core helices and two additional
helices were extended and the amino-acid side chains were
ﬁtted into electron density (Figs. 4d and 4e). Further model
rebuilding and reﬁnement is in progress, with the current free
R factor being just below 30% at 2.2 A˚ resolution.
To estimate the success of density modiﬁcation at different
stages, the model phases were compared with those from the
ﬁnal SRGAP2 model. The SHELXE procedure conducted
with both XDS and DIALS 2.2 A˚ resolution data sets and the
original polyalanine MR solution did not improve the phases,
with a resulting mean phase error of 86.2 at 3.0 A˚ resolution.
After the original model reﬁnement,DMMULTImulti-crystal
averaging and phase combination in REFMAC, the mean
phase error was 84.7 at 3.0 A˚ resolution.
The helix-rebuilt model which contained three core and two
additional helices had a mean phase error of 75.4 at 3.0 A˚
resolution. Six cycles of SHELXE global auto-tracing at 2.7 A˚
resolution resulted in no improvement in phases, with a mean
phase error of 78.0 and 77.1 for the XDS and DIALS data,
respectively. The phase improvement was signiﬁcant at 2.2 A˚
resolution, with a mean phase error of 72.4 and 66.1 at 3.0 A˚
resolution for the XDS andDIALS data, respectively, after six
cycles of SHELXE. ARP/wARP failed to build a model at this
stage, with the mean phase error increasing to 83.0.
The mean phase differences between each of the reﬁned
potential solutions 1–3 and the ﬁnal SRGAP2 model are 90.
This conﬁrms that all of these potential solutions were wrong,
and that a molecular symmetry-constrained systematic search
was the best method for SRGAP2 structure solution.
3.6. Application of the molecular symmetry-constrained
search to other F-BAR family members
Finally, we tested whether the molecular symmetry-
constrained search approach could be applied to structure
solution of the wider family of F-BAR domains, and selected
data and models from three representative examples: (i)
Rgd1p (PDB entry 4wpe), containing a single protomer per
asymmetric unit, for which the molecular symmetry-
constrained search is reduced to two searches in one dimen-
sion, (ii) Imp2 (PDB entry 5c1f), containing an F-BAR dimer
in the asymmetric unit, which requires two four-dimensional
searches (a translation search for a table of orientations) and
(iii) FCHo2 (PDB entry 2v0o), which has a more complex
crystal arrangement in a C-centred monoclinic unit cell and
contains three protomers in its asymmetric unit, with one of
dimers located on a crystallographic dyad.
The three proteins share25% identity over85% of their
sequences, and their structures were solved by experimental
phasing. For each case, search models (polyalanine six-helix
core bundles) derived from the other two structures were
used. The native Patterson synthesis of all three of the above
F-BAR structures contained phantom peaks close to the
origin, similar to those shown in Fig. 4(c).
Since the self-rotation and Patterson functions were difﬁcult
to interpret for the FCHo2 data, we concluded that this case is
not a good candidate for the molecular symmetry-constrained
search.
A molecular symmetry-constrained search (two one-
dimensional searches) for Rgd1p with both the Imp2 and
FCHo2 search models gave high-contrast solutions. The
monomer of Imp2 was positioned with a misset angle of
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2.1 and within 0.5 A˚ of the correct solution according to
SOLUTION_CHECK (Vagin et al., 1998). This solution could
be easily reﬁned without manual model rebuilding. The
monomer of FCHo2 was positioned with a signiﬁcantly higher
rotational misset of 7.2 and a displacement of 3.0 A˚. This MR
solution could not be reﬁned, which is in line with the much
higher structural similarity between Rgd1p and Imp2 (in spite
of having a comparable sequence identity between the three
proteins).
The structure of the Imp2 F-BAR domain (PDB entry 5c1f)
was previously solved by experimental phasing with a speciﬁc
reference to difﬁculties in MR (McDonald et al., 2016). The
asymmetric unit of space group C2 contains a dimeric Imp2
molecule with the direction of the molecular dyad (polar
angles 67.6, 90.0, 180.0) clearly visible in the self-rotation
function calculated by MOLREP. Molecular symmetry-
constrained searches for both the FCHo2 and Rgd1p models
has clearly identiﬁed the correct orientations of both mole-
cules (these had the highest TF scores) but could not position
the centre of mass of either dimeric model. The orientations of
protomers A and B of FCHo2 were found with misset angles
of 4.5 and 3.1, respectively, and the Rgd1p protomers had
misset angles of 2.3 and 3.8.
To facilitate the model positioning, the Imp2 data were
expanded to space group P1 in the same C-centred setting
using CCP4 (Winn et al., 2011), and both FCHo2 and Rgd1p
models in the correct orientation were subjected to 90 cycles
of REFMAC5 jelly-body reﬁnement in this space group. This
approach is related to the PC reﬁnement used to discriminate
between correct and incorrect orientations of the search
model in X-PLOR and CNS by preliminary reﬁnement in the
triclinic unit cell (Bru¨nger, 1996). Preliminary reﬁnement in
P1 of models in the correct orientation is commonly used for
model improvement since there is no ﬁxed origin in the
triclinic cell.
No improvement in the FCHo2 model was achieved by the
triclinic unit-cell reﬁnement and no translation solution could
be found for the preliminary reﬁned model. The Rgd1p model
was improved after reﬁnement in P1, with misset angles of 1.2
and 4.9 for the two protomers. The search for this reﬁned
model in space group C2 with varying resolution limits of 3, 4
and 4.5 A˚ gave a consistent TF solution, bringing the centres
of mass of model protomers A and B within 0.46 and 0.73 A˚
of their matches in the Imp2 F-BAR structure. REFMAC
reﬁnement of the identiﬁed TF solution in the C2 space group,
followed by ARP/wARP, SHELXE and further ARP/wARP
procedures, without any manual model rebuilding, resulted in
a model which reﬁned to a free R factor of 42.5% (mean phase
difference to the ﬁnal model of 50.7) and contained 341
residues out of 616 of Imp2 F-BAR, with 238 residues docked
in sequence.
4. Discussion
In this work, we met both biochemical and crystallographic
challenges. Both were resolved thanks to our prior knowledge
about the structural organization and particular properties of
SRGAP2 and of F-BAR domains in general. Biochemically,
the protein fragment of interest, the F-BARx domain of
SRGAP2, could not be isolated to high enough homogeneity
after recombinant expression using standard approaches, i.e.
different expression systems and fusion proteins. The crystallo-
graphic obstacles to reach a molecular-replacement solution
included poor search models, the tendency of coiled coils to
generate native Patterson peaks and the appearance of ‘ghost
helices’ in density modiﬁcation and reﬁnement.
4.1. RhoGAP-SH3 has a chaperone-like effect on F-BARx
folding
The observation that intact SRGAP4, and SRGAP2
constructs that include the F-BARx-RhoGAP-SH3 domains,
can be isolated to high homogeneity while the F-BARx alone
cannot, led us to realise that the RhoGAP-SH3 module may
have a chaperone-like effect on the folding and stability of the
F-BARx. Therefore, in order to obtain F-BARx suitable for
crystallography, we co-expressed it together with the amino
half of SRGAP2 that contains the RhoGAP-SH3 domains.
Indeed, this strategy had a dramatic positive effect on the
amounts and quality of the soluble F-BARx that we could
isolate.
4.2. Molecular symmetry facilitates MR search solution and
validation
Three unsuccessful attempts to phase SRGAP2 F-BARx by
MR produced signiﬁcantly different potential solutions, none
of which could be reﬁned to an Rfree of below 45%. These
solutions had a common, but so far under-reported feature,
which was probably related to the difﬁculties mentioned for
MR of coiled-coil proteins by Dauter (2015). The electron
density after partial reﬁnement and density modiﬁcation
contained so-called ‘ghost helices’. Addition of these helices
did not improve the reﬁnement statistics of the structures,
which remained distinct from each other.
In the absence of high-resolution data, a different approach
was required which would guarantee the correct positioning of
a starting partial structure. The conserved structure of the six-
helical bundle in F-BAR domain dimers allowed us to adapt a
molecular symmetry-constrained systematic search to the case
of a molecular dimer located on a crystallographic axis. Only
360 orientations were tested, with the centre of the bundle
ﬁxed on a crystallographic dyad. Although only 13% of
SRGAP2 F-BARx atoms (polyalanine model) were thus
positioned, all additional helical features present in the
electron-density maps could now be added to the model with
conﬁdence.
We also demonstrate that a molecular symmetry-
constrained systematic search can be a useful tool in solution
of some other BAR domain proteins. Although Rgd1p, Imp2
and FCHo2 have equivalent sequence identity at around 25%,
an FCHo2-based model proved to be less useful than the other
two proteins. Superposition of the ﬁnal structures showed that
Rgd1p and Imp2 are signiﬁcantly closer to each other than to
FCHo2, a fact that was not detectable at the primary-structure
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level. Therefore, assemblies of superimposed models, such as
those used in Phaser, BALBES or MoRDa, would produce
better search models for molecular symmetry-constrained
search.
Strong phantom peaks in the direction of axes of helical
stretches separated by a helical turn distance were present
in the native Patterson synthesis calculated with SRGAP2
F-BARx (Fig. 4c). Owing to these features, signiﬁcant TF
peaks were observed not only when the dimeric search model
in the correct orientation was positioned on the crystallo-
graphic dyad, but also when the model was shifted away from
it by a helical turn distance. The MOLREP score function
(correlation) in some cases was higher for the shifted model.
To ensure that the centre of mass of the MR solution is located
at the origin, the number of translation-function peaks in
MOLREP was limited to one, since the highest value of the TF
was always observed when the molecular dyad of the model
coincided with the crystallographic axis.
4.3. Helical features in electron-density maps
As shown in, for example, Luzzati (1953), the Fo  Fc maps
reveal features missing from the model with the maximum
weight of 1/2. The limiting value corresponds to a situation
when the modelled part of the crystal structure contains no
errors and the missing part of the structure is small.
A situation in which molecular replacement produces the
correct orientation of the search model, but in an incorrect
position, can be considered in similar terms. To simplify things,
assume one molecule per asymmetric unit. The true structure
(from which the observed diffraction data are derived) can be
translated such that molecules in a selected orientation in the
true structure overlap with those in the model to a signiﬁcant
extent. Here, the term crystal structure designates an inﬁnite
periodic structure, not the asymmetric unit. Hence, the
combination of the model phases and measured data leads to
the appearance of new artefactual features that do not exist
in the true structure. These appearances occur in a position
relative to the selected subset of molecules in the model and
not to the true origin. If a different reference subset of
molecules is selected, in a different orientation, the same
considerations apply, but require a different translation;
subsets are related by the symmetry operation of the space
group, and the number of different subsets equals the number
of point-group operations. This consideration shows that each
new feature in the difference map is duplicated at different
positions, and its weight is no higher than 1/2 divided by the
number of crystal point-group operations. Such maps are in
most cases non-interpretable, but in low-symmetry space
groups, the strongest features, such as helices, may still be
recognizable although their locations have nothing to do with
the true structure (hence the term ‘ghosts’).
Translational NCS (Read et al., 2013) presents a special
case, in which the maximum weight for missing substructures
may be higher than 1/2. The limiting value of 1 is achieved, e.g.
in an artiﬁcial example, where the true structure is represented
by a cell which is twice the size, with one of the crystallo-
graphic translations being treated as an NCS translation, while
every second molecule in each molecular array generated by
that translation is removed from the model. It is therefore
expected that for the structure with several nearly parallel
helices (which can be treated as related by translational NCS)
the density for helices not present in the initial model remains
interpretable for signiﬁcantly larger model errors than it
would have been for missing parts in a globular protein. This
effect proved to be critical for the model-building procedure
of SRGAP2 described in this article.
On the other hand, the same effect was apparently
responsible for the appearance of misleading ‘ghost helices’ in
initial attempts to solve the SRGAP2 structure, when several
helices in the potential MR solutions 1–3 had the correct
orientation and relative position but were positioned wrongly
in relation to the crystallographic symmetry elements in C2. It
is worth mentioning here that ‘ghost density’ was also reported
for the data collected from partially disordered crystals, where
it was attributed to interference terms between adjacent
crystal domains (see, for example, Ponnusamy et al., 2014); our
crystals were single crystals and the misleading features in the
difference maps were owing to the use of incorrect models for
the generation of these maps.
4.4. Refinement and density modification
It appears that the several density-modiﬁcation techniques
used in SRGAP2 model rebuilding and reﬁnement were useful
at different stages of the project. In early stages, multi-crystal
averaging proved to be a robust phase-improvement proce-
dure, even though only a single unit-cell parameter difference
between crystals 1 and 2 was explored. SHELXE and ARP/
wARP were sensitive to low completeness of the starting
model and became useful at later stages, when a more
complete model became available and higher resolution data
were used.
Even a conservative model-building approach could not
prevent secondary-structure breakdown when the positions of
the main-chain atoms of residues in helices 1–3 were adjusted
in the course of positional reﬁnement. Furthermore, main-
chain torsion angles were not preserved, although residues in
newly built helical stretches were not affected. Replacement
of the starting three helices by ideal helical stretches was
required for further reﬁnement and model building.
5. Conclusions
The co-expression of SRGAP2 F-BARx with the C-terminal
RhoGAP and SH3 domains of SRGAP2 allowed the
production of signiﬁcant quantities of soluble SRGAP2
F-BARx.
A molecular symmetry-constrained systematic search has
successfully been applied for structure solution of the human
SRGAP2 F-BARx protein (and two other F-BAR proteins
that were previously determined by experimental phasing),
using the conserved six-helix bundle core structure of the
F-BAR domain family. This has allowed solution and reﬁne-
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ment of a medium-resolution structure using a remote model
with only 19% sequence identity, which represented 13% (in
the polyalanine model) of the asymmetric unit contents. The
extension of resolution to include weak anisotropic data was
important for successful density modiﬁcation and reﬁnement
of SRGAP2.
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